PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.61
ESG score below 80% of AXSM's 86.90. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
55.53
Environmental score below 80% of AXSM's 97.47. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
56.83
Social score below 80% of AXSM's 98.82. Jim Chanos would check for potential social license and litigation risks.
57.48
Governance score 80-90% of AXSM's 64.41. Walter Schloss would scrutinize management accountability and board independence.